Influencing factors on the NMP-22 urine assay: an experimental model

BACKGROUND: The commercial NMP-22 urine assays for bladder cancer (BCa) detect nuclear mitotic apparatus protein 1 (NUMA1) using monoclonal antibodies. It remains unclear whether these assays are monitoring a tumor antigen or some other phenomenon associated with the disease state. In this study, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Makito, Goodison, Steve, Giacoia, Evan Gomes, Rizwani, Wasia, Ross, Shanti, Rosser, Charles J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480828/
https://www.ncbi.nlm.nih.gov/pubmed/22928931
http://dx.doi.org/10.1186/1471-2490-12-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3480828/
https://www.ncbi.nlm.nih.gov/pubmed/22928931
http://dx.doi.org/10.1186/1471-2490-12-23

Ejemplares similares